MCM
INMB icon

MAI Capital Management’s INmune Bio INMB Stock Holding History

MAI Capital Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.83K Sell
4,271
-204
-5% -$291 ﹤0.01% 3532
2025
Q4 		$6.98K Sell
4,475
-3,318
-43% -$5.92K ﹤0.01% 2992
2025
Q3 		$16.1K Sell
7,793
-40,445
-84% -$92.6K ﹤0.01% 2508
2025
Q2 		$111K Sell
48,238
-58,559
-55% -$430K ﹤0.01% 1430
2025
Q1 		$834K Buy
106,797
+6,030
+6% +$47.9K 0.01% 677
2024
Q4 		$471K Sell
100,767
-59,991
-37% -$313K ﹤0.01% 865
2024
Q3 		$866K Buy
160,758
+176
+0.1% +$1.25K 0.01% 597
2024
Q2 		$1.42M Sell
160,582
-20,828
-11% -$205K 0.01% 500
2024
Q1 		$2.13M Buy
181,410
+83,398
+85% +$1.01M 0.02% 392
2023
Q4 		$1.1M Buy
98,012
+602
+0.6% +$5.05K 0.01% 440
2023
Q3 		$659K Buy
97,410
+38,233
+65% +$317K 0.01% 543
2023
Q2 		$537K Buy
59,177
+39,534
+201% +$318K 0.01% 611
2023
Q1 		$127K Buy
+19,643
New +$158K ﹤0.01% 976

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAI Capital Management's INMB Position: Q1 2026 in Review

MAI Capital Management reduced its INmune Bio (INMB) stake by 4.6% in Q1 2026, selling an estimated $291 and leaving 4,271 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3532.

MAI Capital Management first reported a position in INMB in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.13M in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • MAI Capital Management held 4,271 shares of INmune Bio worth $4.83K as of Q1 2026.
  • MAI Capital Management sold 204 INmune Bio shares in Q1 2026, an estimated $291.
  • INmune Bio made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3532 holding.
  • MAI Capital Management first reported a position in INmune Bio in Q1 2023 and has held it in 13 quarters since.
  • MAI Capital Management's INmune Bio position peaked at $2.13M in Q1 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.